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Corticosteroids are widely use for the treatment of var-
ious diseases. Long-term use of corticosteroids may lead
to development of Cushing syndrome and hypothalamic
pituitary adrenal axis suppression. However, iatrogenic
Cushing syndrome from absorption of topical steroids
to systemic circulation is less common comparing to
parenteral or oral use. Infantile age group have greater
risks for systemic side effects of the drugs because their
skin has poorly developed barrier function and large
surface area.
We reported a 5-month-old female child was admitted
to our hospital with puffiness of face and excessive weight
gain after 4 months old. She was born at term with an
uneventful pregnancy with a birth weight of 3.4 kg. Her
body weight was 8.2 kg (+2SDS), height was 63.5 cm
(+0.2SDS). Physical examination showed her was moon
face appearance, generalized obesity, hirsutism and buffalo
hump. There were few erythema and weeping present at
skin fold areas. Blood pressure was 105/68 mmHg (>95th
percentile). Past history revealed that the child had diaper
dermatitis at 3.5 month of age. She was prescribed a topi-
cal combination drug containing nystatin, neomycin, gra-
micidin and triamcinolone acetonide from private
pediatric clinic. Since then she was applying the drug
3-4 times daily on neck, axilla, diaper area and all skin fold
areas. Totally drug usage was 30 g in 6 weeks. Investiga-
tions showed hemoglobin of 15 g/dL, white blood cell
count 18,240/mm3, platelet count 471,000/mm3, blood
glucose 74 mg/dL and normal electrolyte, renal and liver
function. Ultrasonography of whole abdomen revealed no
abnormality. Random PM cortisol was low (0.2 mcg/dL).
Secondary adrenal insufficiency was suspected. 1-mcg
ACTH stimulation test was done and the peak cortisol
was 1.9 mcg/dL. Therefore, exogenous Cushing syndrome
and secondary adrenal insufficiency due to overuse of
topical combination drug which containing moderate
potency steroid was diagnosed. She was promptly treat-
ment by discontinued applying the drug and administered
steroid during stress.
This report highlights the importance of prolonged use
of moderate potency topical steroids can causes hypotha-
lamic pituitary adrenal axis suppression and Cushing syn-
drome, especially during infantile period. Therefore,
limiting the use of moderate- to high-potency topical
steroids in children and provide information about
potential adverse effects to the caregivers are crucial.
Written informed consent was obtained from the
patient for publication of this abstract and any accompa-
nying images. A copy of the written consent is available
for review by the Editor of this journal.
Published: 28 April 2015
doi:10.1186/1687-9856-2015-S1-P45
Cite this article as: Nantarakchaikul and Nimdet: An infantile exogenous
Cushing syndrome caused by topical steroid. International Journal of
Pediatric Endocrinology 2015 2015(Suppl 1):P45.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Suratthani Central Hospital, Suratthani, Thailand
Nantarakchaikul and Nimdet International Journal of Pediatric Endocrinology 2015, 2015(Suppl 1):P45
http://www.ijpeonline.com/content/2015/S1/P45
© 2015 Nantarakchaikul and Nimdet; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
